Posts

New England Journal of Medicine publishes outcomes from...

A significant survival improvement for adults with newly diagnosed BCR::ABL1-neg...

The aroma of tomato resistance

In a recent study published on the cover of the Plant Physiology journal, the IB...

Foam fluidics showcase Rice lab’s creative approach to ...

HOUSTON – (July 24, 2024) – When picturing next-generation wearables and robotic...

It’s got praying mantis eyes

Self-driving cars occasionally crash because their visual systems can’t always p...

WVU scientists taking a close look at what causes immun...

A West Virginia University immunologist is exploring how the interaction between...

Rice researchers develop innovative battery recycling m...

A research team at Rice University led by James Tour, the T.T. and W.F. Chao Pro...

Pacific Northwest launches clean hydrogen energy hub

RICHLAND, Wash.—The Pacific Northwest is set to begin work building out a clean ...

New gene therapy approach shows promise for Duchenne mu...

INDIANAPOLIS – Indiana University School of Medicine researchers have made a sig...

Timing matters: Scripps Research study shows ways to im...

LA JOLLA, CA—When seemingly healthy people receive an alert from a wearable sens...

Chemical analyses find hidden elements from renaissance...

In the Middle Ages, alchemists were notoriously secretive and didn’t share their...

Save your data on printable magnetic devices? New laser...

The proliferation of all things digital doesn’t mean that printing technology is...

Telix raises $398m to advance kidney and brain cancer r...

Telix is eyeing an expansion of the diagnostic imaging indications for its asset...

Podcast #5: Doing Digital Deals in Life Sciences | Deal...

Final podcast in Sterling's series, examining how a range of factors influence t...

Agilent agrees to acquire BIOVECTRA for $925m

Agilent Technologies has announced a definitive agreement for the acquisition of...

FDA approves Samsung Bioepis’ EPYSQLI as Soliris biosim...

Samsung Bioepis has announced the approval of EPYSQLI BLA by the US Food and Dru...

Johnson & Johnson submits sNDA for SPRAVATO to treat de...

Johnson & Johnson is seeking approval for SPRAVATO for treatment-resistant depre...